pHyph
Sponsors
Gedea Biotech AB
Conditions
Bacterial VaginosisBacterial Vaginosis (BV)Vulvovaginal Candidiasis (VVC)
Unknown Phase
A Randomised, Partly-blinded Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Bacterial Vaginosis Compared With an Untreated Control Group
CompletedNCT06123299
Start: 2023-11-20End: 2024-09-04Updated: 2025-03-13
An Open Single-armed Investigation to Evaluate the Safety of pHyph Following a Prolonged Treatment Duration in Adult Women With Bacterial Vaginosis
CompletedNCT07394777
Start: 2026-01-15End: 2026-04-01Updated: 2026-04-13
An Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Vulvovaginal Candidiasis Compared With an Untreated Control Group
Active, not recruitingNCT07405853
Start: 2026-03-03End: 2026-10-01Target: 48Updated: 2026-05-14